🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Wells Fargo maintains UnitedHealth shares at Equal Weight on Q1 result

EditorNatashya Angelica
Published 17/04/2024, 18:38

On Wednesday, Wells Fargo sustained its Equal Weight rating on UnitedHealth Group (NYSE:UNH) with a constant price target of $525.00. The firm's analysis acknowledged UnitedHealth's first-quarter results of 2024 as being more favorable than anticipated despite certain operational challenges.

The company's reaffirmation of its adjusted earnings per share (EPS) guidance, even in the face of setbacks from Change Healthcare (NASDAQ:CHNG), was highlighted as a particularly positive sign.

UnitedHealth Group has expressed confidence in its ability to improve the performance of Change Healthcare and navigate the complexities of a tougher Medicare Advantage (MA) funding environment.

The analyst's statement shed light on the additional $800 million in reserves set aside by UnitedHealth in the first quarter of 2024. This action was taken to address potential disruptions in the timing of claims receipts, which are strictly associated with services provided within the first quarter and not related to previous years.

The reserve increase is a precautionary measure to counter the possibility that the claims inventory at the end of the first quarter may have been lower than usual due to disruptions impacting Change Healthcare. UnitedHealth Group anticipates that the $800 million earmarked may ultimately prove to be a conservative estimate, suggesting the company's expectation to manage the situation effectively.

InvestingPro Insights

UnitedHealth Group's (NYSE:UNH) recent performance and strategic decisions have been noteworthy, as reflected by Wells Fargo's steady rating and the company's optimistic outlook despite a challenging environment.

Delving into the financials, UnitedHealth's market capitalization stands at a robust $432.29 billion, indicating its significant presence in the healthcare industry. Investors should note that the company is trading at a P/E ratio of 19.95, which is relatively high when considering near-term earnings growth, suggesting expectations of strong future performance.

Aligning with the company's confidence, InvestingPro Tips highlight UnitedHealth's consistent track record of raising its dividend for 14 consecutive years, with a dividend yield of 1.65% as of the latest data.

This is indicative of the company's commitment to returning value to shareholders. Additionally, the company's management has been actively engaging in share buybacks, which can be a positive signal regarding the leadership's belief in the company's value. For investors looking for stability, UnitedHealth's low price volatility might be an attractive trait.

For those seeking deeper analysis and more InvestingPro Tips, there are 10 additional insights available on UnitedHealth Group, which can be explored further for informed investment decisions. To access these insights and optimize your investment strategy, consider using the promo code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription at InvestingPro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.